Walpar Nutritions IPO Details
Walpar Nutritions IPO description – Walpar Nutritions offers a wide range of Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products. The company develops, manufactures and commercializes HERBO-NUTRACEUTICAL products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under Nutraceuticals.
The company has product approvals under the license issued by FSSAI (Food Safety and Standards Authority of India) and AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy) department for manufacturing of Tablets, Capsules, Oral Liquids and Ointments and also for analysis of Chemical, Instrumental & Microbiology.
Walpar has developed more than 100 formulations and 1000 brands for third party for domestic market under different segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Sports nutrition.WALPAR manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet, powders and effervescent tablets.
Its manufacturing unit is located at 4-9, and 21 at Shyam Estate, Santej, Ta: Kalol, Gandhinagar. At present, the company has installed capacity of manufacturing of approx. 30 Lakhs tablets per month, 12.50 Lakhs capsules per month, 1.50 Lakhs oral liquids of (ranging from 15 ML to 200 ML) per month, and 2.00 Lakhs Sachets of (ranging from 1 gm to 10 gms) per month. It holds WHO, HACCP, HALAL, Kosher and ISO 9001:2015 certificate issued by Independent agencies and has also applied for patents for three products.
Promoters of Walpar Nutritions – Mr Kalpesh Pravinchandra Ladhawala, Mr Tanmaykumar Ashwinbhai Shah And Mrs Sejal Kalpesh Ladhawala
| Walpar Nutritions IPO details | |
| Subscription Dates | 30 June – 5 July 2021 |
| Price Band | INR55 per share |
| Fresh issue | 1,200,000 shares (INR6.60 crore) |
| Offer For Sale | Nil |
| Total IPO size | 1,200,000 shares (INR6.60 crore) |
| Minimum bid (lot size) | 2,000 shares |
| Face Value | INR10 per share |
| Retail Allocation | 50% |
| Listing On | NSE Emerge SME platform |
Walpar Nutritions financial performance (in INR lakhs)
| Â | FY2018 | FY2019 | FY2020 | 9M FY2021 |
| Revenue | 644.53 | 1,282.27 | 1,671.27 | 1,278.75 |
| Expenses | 641.77 | 1,270.46 | 1,652.25 | 1,239.60 |
| Net income | 0.33 | 6.88 | 12.18 | 28.55 |
| Net margin (%) | 0.1 | 0.5 | 0.7 | 2.2 |
Registrar of Walpar Nutritions IPO
Skyline Financial Services Pvt Ltd
A/505, Dattani Plaza,
Andheri Kurla Road Safeed Pool
Andheri (E), Mumbai- 400072
Maharashtra, IndiaÂ
Phone: +91 22 2851Â 1022
Email:Â [email protected]
Website: www.skylinerta.com
Valuation of Walpar Nutritions IPO (FY2020)
Earnings Per Share (EPS): INR0.41
Price/Earnings (PE ratio): 135.44
Return on Net Worth (RONW): 6.53%
Net Asset Value (NAV): INR6.22 per share
Walpar Nutritions IPO Subscription Details
| Day |
Subscription (no. of times) |
| Day 1 |
0.35 |
| Day 2 |
2.37 |
| Day 3 |
4.22 |
| Day 4 |
9.48 |
| Â | Â |
Walpar Nutritions Contact Details
Walpar Nutritions Limited
2nd Floor, L5: 377 PLOT:5,
Opp. Sabarmati, Khatraj,
Taluka kalol, Gandhinagar-382721
Phone: +91 2764 662626
Email: [email protected]
Website: www.walparnutritions.com
Walpar Nutritions IPO Allotment Status
Walpar Nutritions IPO allotment status is now available on Skyline Financial Services’ website. Click on this link to get allotment status.Â
Listing Performance of Walpar Nutritions
IPO Opening Date: 30 June 2021
IPO Closing Date: 5 July 2021
Finalisation of Basis of Allotment: 8 July 2021
Initiation of refunds: 9 July 2021Â
Transfer of shares to demat accounts: 9 July 2021Â
Listing Date: 13 July 2021Â
Opening Price on NSE SME: INR59.95 per share (up 9% from IPO price)
Closing Price on NSE SME: INR57.00 per share (up 3.64% from IPO price)
